Estabrook Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.2K | Hold |
475
| – | – | 0.01% | 207 |
|
|
2025
Q1 | $34.9K | Hold |
475
| – | – | 0.01% | 201 |
|
|
2024
Q4 | $31.1K | Hold |
475
| – | – | ﹤0.01% | 213 |
|
|
2024
Q3 | $37K | Hold |
475
| – | – | 0.01% | 213 |
|
|
2024
Q2 | $37K | Hold |
475
| – | – | 0.01% | 213 |
|
|
2024
Q1 | $32.2K | Hold |
475
| – | – | 0.01% | 222 |
|
|
2023
Q4 | $32K | Hold |
475
| – | – | 0.01% | 222 |
|
|
2023
Q3 | $32.2K | Hold |
475
| – | – | 0.01% | 226 |
|
|
2023
Q2 | $34K | Hold |
475
| – | – | 0.01% | 232 |
|
|
2023
Q1 | $33K | Hold |
475
| – | – | 0.01% | 239 |
|
|
2022
Q4 | $32.2K | Hold |
475
| – | – | 0.01% | 239 |
|
|
2022
Q3 | $26K | Hold |
475
| – | – | ﹤0.01% | 249 |
|
|
2022
Q2 | $31.4K | Hold |
475
| – | – | 0.01% | 248 |
|
|
2022
Q1 | $31.5K | Hold |
475
| – | – | ﹤0.01% | 253 |
|
|
2021
Q4 | $27.7K | Buy |
+475
| New | +$27.7K | ﹤0.01% | 270 |
|
|
2018
Q4 | – | Sell |
-170
| Closed | -$6.73K | – | 340 |
|
|
2018
Q3 | $6.73K | Buy |
+170
| New | +$6.73K | ﹤0.01% | 313 |
|